New research from links modest, nonpharmacological weight loss in midlife to lower long-term risks of chronic disease and early death.
Hims & Hers and Novo Nordisk are teaming to expand affordable access to weight loss treatments, launching a bundled Wegovy offering.
New data shows U.S. consumer spending on GLP-1 drugs like Ozempic, Wegovy and Mounjaro soared from $13.7B to $71.7B between 2018 and 2023.
Form launched its first-ever nutrition-based program, Transform from Within, with dietitian Shira Barlow, MS, RD.
Seca has just released Treatment Tracker, directly linking patient treatment plans with body composition data.
BODi and Hello Alpha have teamed up to merge fitness and virtual healthcare for a holistic approach to health and wellness.
A longtime executive with the American Council on Exercise (ACE), Bryant is helping lead the fitness-as-medicine movement.
Longevity-focused telehealth platform Ageless Rx has added oral GLP-1 drops as a needle-free option for weight loss consumers.
The study, which analyzed data from over 60,000 members, demonstrated the potential viability of telehealth for weight loss.
A fixture in towns across Illinois, Fitness Premier becomes one of the first affordable gym brands to launch a medical weight loss program.
Sign Up to Our Newsletter
